Ikaria(R) Recalls INOMAX(R) DS Drug-Delivery System
August 09, 2010
August 09, 2010
CLINTON, N.J., Aug. 9 -- The U.S. Department of Health & Human Services' Food & Drug Administration issued the following recall notice:
Ikaria, Inc. announced today that its INOMAX(R) DS drug-delivery systems in the United States are being voluntarily recalled due to the potential failure of a pressure switch which may have an impact on the administration of INOMAX(R) (nitric oxide) for inhalation to patients. This potential failure was identified by Ikaria as part of . . .
Ikaria, Inc. announced today that its INOMAX(R) DS drug-delivery systems in the United States are being voluntarily recalled due to the potential failure of a pressure switch which may have an impact on the administration of INOMAX(R) (nitric oxide) for inhalation to patients. This potential failure was identified by Ikaria as part of . . .